These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 5755701

  • 1. Glaucoma, miotic therapy and cataract. 3. Visual loss due to lens changes in glaucoma eyes treated with paraoxon (Mintacol), echothiophate (phospholine iodide) or pilocarpine.
    Axelsson U.
    Acta Ophthalmol (Copenh); 1968; 46(4):831-45. PubMed ID: 5755701
    [No Abstract] [Full Text] [Related]

  • 2. Glaucoma, miotic therapy and cataract. V. Studies on the lens in glaucoma eyes after discontinuance of echothiophate (phospholine iodide) therapy.
    Axelsson U.
    Acta Ophthalmol (Copenh); 1969; 47(4):1049-56. PubMed ID: 5394838
    [No Abstract] [Full Text] [Related]

  • 3. The frequency of cataract after miotic therapy.
    Axelsson U, Holmberg A.
    Acta Ophthalmol (Copenh); 1966; 44(3):421-9. PubMed ID: 5953238
    [No Abstract] [Full Text] [Related]

  • 4. Glaucoma, miotic therapy and cataract. VI. Experimental studies on the guinea pig eye.
    Axelsson U.
    Acta Ophthalmol (Copenh); 1969; 47(4):1057-67. PubMed ID: 5394839
    [No Abstract] [Full Text] [Related]

  • 5. Glaucoma, miotic therapy and cataract. I. The frequency of anterior subcapsular vacuoles in glaucoma eyes treated with echothiophate (Phospholine Iodide), pilocarpine or pilocarpine-eserine, and in nonglaucomatous untreated eyes with common senile cataract.
    Axelsson U.
    Acta Ophthalmol (Copenh); 1968; 46(1):83-98. PubMed ID: 5694669
    [No Abstract] [Full Text] [Related]

  • 6. Influence of various miotics on cataract formation.
    Abraham SV, Teller JJ.
    Br J Ophthalmol; 1969 Dec; 53(12):833-8. PubMed ID: 5386373
    [No Abstract] [Full Text] [Related]

  • 7. Uniocular miotic therapy.
    Levene RZ.
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1975 Dec; 79(2):OP376-80. PubMed ID: 1145961
    [Abstract] [Full Text] [Related]

  • 8. Lens opacities in glaucoma patients on phospholine iodide therapy.
    De Roetth A.
    Trans Ophthalmol Soc U K (1962); 1966 Dec; 86():89-100. PubMed ID: 5226620
    [No Abstract] [Full Text] [Related]

  • 9. Cataract formation during miotic treatment for chronic open-angle glaucoma.
    Tarkkanen A, Karjalainen K.
    Acta Ophthalmol (Copenh); 1966 Dec; 44(6):932-9. PubMed ID: 6012880
    [No Abstract] [Full Text] [Related]

  • 10. Anticholinesterase drugs and cataracts.
    Shaffer RN, Hetherington J.
    Trans Am Ophthalmol Soc; 1966 Dec; 64():204-16. PubMed ID: 6007355
    [No Abstract] [Full Text] [Related]

  • 11. Effect of echothiophate iodide on the lens.
    Morton WR, Drance SM, Fairclough M.
    Am J Ophthalmol; 1969 Dec; 68(6):1003-10. PubMed ID: 5362877
    [No Abstract] [Full Text] [Related]

  • 12. Lens opacities in glaucoma patients on phospholine iodide therapy.
    De Roetth A.
    Am J Ophthalmol; 1966 Oct; 62(4):619-28. PubMed ID: 5929123
    [No Abstract] [Full Text] [Related]

  • 13. [Phospholine iodide in the management of glaucoma].
    Hoffmann K.
    Klin Monbl Augenheilkd; 1971 Mar; 158(3):413-7. PubMed ID: 5573462
    [No Abstract] [Full Text] [Related]

  • 14. THE MANAGEMENT OF "EARLY" CHRONIC GLAUCOMA WITH THE LONG-ACTING MIOTIC, PHOSPHOLINE IODIDE.
    JACKMAN N.
    Am J Ophthalmol; 1965 May; 59():899-902. PubMed ID: 14288933
    [No Abstract] [Full Text] [Related]

  • 15. [Phospholine iodide and opacity of the lens].
    Dake CL, Kerlen CH.
    Ned Tijdschr Geneeskd; 1968 Oct 19; 112(42):1898-901. PubMed ID: 5686456
    [No Abstract] [Full Text] [Related]

  • 16. Incidence of lens changes in patients treated with echothiophate iodide.
    Thoft RA.
    Arch Ophthalmol; 1968 Sep 19; 80(3):317-20. PubMed ID: 5670686
    [No Abstract] [Full Text] [Related]

  • 17. Glaucoma, miotic therapy and cataract. II. The frequency of anterior subcapsular vacuoles in glaucoma eyes treated with paraoxon (Mintacol).
    Axelsson U.
    Acta Ophthalmol (Copenh); 1968 Sep 19; 46(1):99-105. PubMed ID: 5694670
    [No Abstract] [Full Text] [Related]

  • 18. Miotics.
    Kanski JJ.
    Br J Ophthalmol; 1968 Dec 19; 52(12):936-7. PubMed ID: 5750171
    [No Abstract] [Full Text] [Related]

  • 19. [Absence of cataractogenic effect of 0.03 percent phospholine iodide].
    Corbel M, Leser C, Lemaire E.
    Bull Soc Ophtalmol Fr; 1971 Dec 19; 71(9):885-9. PubMed ID: 5151034
    [No Abstract] [Full Text] [Related]

  • 20. Lens opacities and organophosphate cholinesterase-inhibiting agents.
    Pietsch RL, Bobo CB, Finklea JF, Vallotton WW.
    Am J Ophthalmol; 1972 Feb 19; 73(2):236-42. PubMed ID: 5015904
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.